0000937556-17-000220.txt : 20171109 0000937556-17-000220.hdr.sgml : 20171109 20171109200710 ACCESSION NUMBER: 0000937556-17-000220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171108 FILED AS OF DATE: 20171109 DATE AS OF CHANGE: 20171109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Yongsam CENTRAL INDEX KEY: 0001403400 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33642 FILM NUMBER: 171192501 MAIL ADDRESS: STREET 1: C/O MASIMO CORPORATION STREET 2: 40 PARKER CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MASIMO CORP CENTRAL INDEX KEY: 0000937556 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 330368882 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 52 DISCOVERY CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-297-7000 MAIL ADDRESS: STREET 1: 52 DISCOVERY CITY: IRVINE STATE: CA ZIP: 92618 4 1 wf-form4_151027601634098.xml FORM 4 X0306 4 2017-11-08 0 0000937556 MASIMO CORP MASI 0001403400 Lee Yongsam C/O MASIMO CORPORATION 52 DISCOVERY IRVINE CA 92618 0 1 0 0 EVP & CIO Common Stock 2017-11-08 4 M 0 5000 30.79 A 74000 D Common Stock 2017-11-08 4 S 0 5000 89.5946 D 69000 D Common Stock 2017-11-08 4 M 0 876 27.25 A 69876 D Common Stock 2017-11-08 4 S 0 876 89.5946 D 69000 D Common Stock 2017-11-09 4 M 0 8100 27.25 A 77100 D Common Stock 2017-11-09 4 S 0 8100 89.3112 D 69000 D Non-Qualified Stock Option (Right to Buy) 30.79 2017-11-08 4 M 0 5000 30.79 D 2009-02-07 2018-02-07 Common Stock 5000.0 0 D Non-Qualified Stock Option (Right to Buy) 27.25 2017-11-08 4 M 0 876 27.25 D 2011-02-11 2020-02-11 Common Stock 876.0 29124 D Non-Qualified Stock Option (Right to Buy) 27.25 2017-11-09 4 M 0 8100 27.25 D 2011-02-11 2020-02-11 Common Stock 8100.0 21024 D The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of August 21, 2017, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $89.00 per share to a high of $90.105 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $89.00 per share to a high of $89.80 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on February 7, 2008 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. This option was granted on February 11, 2010 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. /s/ David J. Van Ramshorst, Attorney-In-Fact 2017-11-09